NCT03606200

Brief Summary

The Swiss Primary Ciliary Dyskinesia (PCD) Registry is a national patient registry that collects information on diagnosis, symptoms, treatment and follow-up of patients with PCD in Switzerland and provides data for national and international monitoring and research.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
665mo left

Started Jan 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jan 2013Dec 2080

Study Start

First participant enrolled

January 1, 2013

Completed
5.4 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 30, 2018

Completed
62.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2080

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2080

Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

68 years

First QC Date

June 11, 2018

Last Update Submit

November 24, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • Height

    Height z-scores calculated based on available national and international references

    every 3 months up to 80 years

  • BMI

    Body Mass Index (BMI) z-scores calculated based on available national and international references

    every 3 months up to 80 years

  • Lung function measurements

    Spirometric indices, particularly Forced expiratory volume in 1 sec (FEV1) and Forced vital capacity (FVC) z-scores calculated based on Global Lung Function Initiative (GLI) reference values

    every 3 months up to 80 years

  • Measurement of nasal nitric oxide using breath analyzer

    Results of nasal nitric oxide measurement, performed for diagnosis

    at study entry (in case patient is <5 years old at study entry, then the outcome will be assessed at age 5

  • Cilia ultrastructure identified using electron microscopy analysis

    Results of electron microscopy analysis of cilia, performed for diagnosis

    at study entry

  • Ciliary beat frequency and beat pattern using video microscopy analysis

    Results of video microscopy analysis of cilia, performed for diagnosis

    at study entry

  • Microbiological culture of respiratory samples

    Results of microbiology cultures of respiratory samples (sputum, cough swabs, throat swabs, ear swabs, bronchoalveolar lavage) expressed in a qualitative (growth or no growth of pathogens) or semiquantitative way (the type of sample depends on the age of the patient and the clinic the sample was collected).

    every 3 months up to 80 years

  • Antibiotic resistance of microbes isolated in microbiological cultures

    Information on antibiotic resistance of microbes isolated in microbiological cultures (see outcome 7) of respiratory samples, expressed either semiquantitatively or by the value of minimum inhibitory concentration.

    every 3 months up to 80 years

  • Chest computed tomography

    Radiological findings from chest computed tomography

    every 3 months up to 80 years

  • Sinus computed tomography

    Radiological findings from sinus computed tomography

    every 3 months up to 80 years

  • Vital status

    Vital status of patient: has the patient died or is he/she still alive and in case of death what was the cause?

    every 3 months up to 80 years

  • Clinical symptoms frequency

    Frequency of respiratory symptoms recorded with a patient or parent-reported questionnaire

    once a year up to 80 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of all ages diagnosed with PCD, who are resident or treated in Switzerland.

You may qualify if:

  • Patients diagnosed with primary ciliary dyskinesia
  • Signed informed consent or assent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bern

Bern, 3012, Switzerland

RECRUITING

Related Publications (3)

  • Goutaki M, Eich MO, Halbeisen FS, Barben J, Casaulta C, Clarenbach C, Hafen G, Latzin P, Regamey N, Lazor R, Tschanz S, Zanolari M, Maurer E, Kuehni CE; Swiss PCD Registry (CH-PCD) Working Group. The Swiss Primary Ciliary Dyskinesia registry: objectives, methods and first results. Swiss Med Wkly. 2019 Jan 13;149:w20004. doi: 10.57187/smw.2019.20004. eCollection 2019 Jan 1.

  • Goutaki M, Husler L, Lam YT, Koppe HM, Jung A, Lazor R, Muller L; Swiss PCD Research Group; Pedersen ESL, Kuehni CE. Respiratory symptoms of Swiss people with primary ciliary dyskinesia. ERJ Open Res. 2022 Apr 11;8(2):00673-2021. doi: 10.1183/23120541.00673-2021. eCollection 2022 Apr.

  • Lam YT, Pedersen ESL, Schreck LD, Husler L, Koppe H, Belle FN, Clarenbach C, Latzin P; Swiss PCD research group; Kuehni CE, Goutaki M. Physical activity, respiratory physiotherapy practices, and nutrition among people with primary ciliary dyskinesia in Switzerland - a cross-sectional survey. Swiss Med Wkly. 2022 Aug 18;152:w30221. doi: 10.4414/smw.2022.w30221. eCollection 2022 Aug 15.

MeSH Terms

Conditions

Ciliary Motility DisordersKartagener Syndrome

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesCiliopathiesAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, InbornBronchiectasisBronchial DiseasesRespiratory System AbnormalitiesDextrocardiaHeart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesSitus Inversus

Study Officials

  • Claudia E Kuehni, Prof

    University of Bern

    PRINCIPAL INVESTIGATOR
  • Myrofora Goutaki, PD, MD-PhD

    University of Bern

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Claudia E Kuehni, Prof

CONTACT

Myrofora Goutaki, PD, MD-PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
80 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2018

First Posted

July 30, 2018

Study Start

January 1, 2013

Primary Completion (Estimated)

December 1, 2080

Study Completion (Estimated)

December 1, 2080

Last Updated

November 25, 2025

Record last verified: 2025-11

Locations